Positive correlation between plasma PCSK9 and tissue factors levels in patients with angiographically diagnosed coronary artery disease and diabetes mellitus

被引:0
|
作者
Mei WANG [1 ]
YanFang LI [1 ,2 ]
YanGing GUO [1 ]
MengMeng CHEN [1 ]
ZhiLi JIANG [1 ]
JunYing SONG [1 ]
机构
[1] Emergency & Critical Care Center,Beijing Anzhen Hospital,Capital Medical University
[2] Beijing Institute of Heart Lung and Blood Vessel
关键词
D O I
暂无
中图分类号
R543.3 [冠状动、静脉疾病]; R587.1 [糖尿病];
学科分类号
摘要
Background Pro-protein convertase subtilisin/kexin type 9(PCSK9) is a secreted protein that influences plasma levels of low-density lipoprotein cholesterol(LDL-C).Both oxidized LDL and tissue factor(TF) contributed to the development of prothrombotic state.The present study aims to explore the relationship between plasma level of PCSK9 and that of TF in patient with coronary artery disease(CAD).Methods From July 2013 to March 2014,we enrolled 197 consecutive patients who underwent coronary angiography because of suspected CAD at Beijing Anzhen Hospital in this study.All patients had no history of using lipid-lowering medication.Of these 197 patients(131male and 66 female,mean age 56.9 ± 11.8 years),81 had angiographicaUy diagnosed CAD.Clinical data were collected.Plasma PCSK9 and TF were measured using enzyme-linked immunosorbent assay(ELISA).Levels of plasma PCSK9 and TF were compared and their correlation analyzed among different patient groups.Results Both plasma levels of PCSK9(279.8 ± 60.4μg/L vs.216.5 ± 45.3μg/L,P < 0.01)and TF(156.4 ± 26.6μg/mL vs.112.1 ± 38.3 ug/L,P < 0.01) were significantly higher in patients with CAD,as compared with those without CAD.Correlation analysis showed plasma level of PCSK9 was significantly correlated with that of TF in both patients with and without CAD.However,multivariate regression analysis after adjustment for age,gender,smoking,alcohol,hypertension and hyperlipidemia showed that only in CAD patients with type 2 diabetes mellitus,there was significant positive correlation between plasma levels of PCSK9 and TF(P = 0.353,P < 0.01).Conclusions The plasma level of PCSK9 is independently and positively associated with that of TF in CAD patients with diabetes mellitus,but not in those without diabetes mellitus.Further study is needed to investigate the underlying mechanism.
引用
收藏
页码:312 / 315
页数:4
相关论文
共 50 条
  • [41] Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease
    Frohlich, J
    Dobiásova, M
    Adler, L
    Francis, M
    PHYSIOLOGICAL RESEARCH, 2004, 53 (05) : 481 - 486
  • [42] Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease
    Boyer, Marjorie
    Levesque, Valerie
    Poirier, Paul
    Marette, Andre
    Mathieu, Patrick
    Despres, Jean-Pierre
    Larose, Eric
    Arsenault, Benoit J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (06) : 1353 - 1361
  • [43] Circulating Levels of Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) are Associated With Monocyte Subsets in Patients With Stable Coronary Artery Disease
    Krychtiuk, Konstantin
    Lenz, Max
    Hohensinner, Philipp
    Distelmaier, Klaus
    Schrutka, Lore
    Kastl, Stefan
    Pfaffenberger, Stefan
    Huber, Kurt
    Hengstenberg, Christian
    Wojta, Johann
    Speidl, Walter S.
    CIRCULATION, 2020, 142
  • [44] Circulating levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) are associated with monocyte subsets in patients with stable coronary artery disease
    Krychtiuk, Konstantin A.
    Lenz, Max
    Hohensinner, Philipp
    Distelmaier, Klaus
    Schrutka, Lore
    Kastl, Stefan P.
    Huber, Kurt
    Dostal, Elisabeth
    Oravec, Stanislav
    Hengstenberg, Christian
    Wojta, Johann
    Speidl, Walter S.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (03) : 512 - 521
  • [45] Association between plasma PCSK9 and gamma-glutamyl transferase levels in diabetic patients
    Cariou, Bertrand
    Le Bras, Maelle
    Langhi, Cedric
    Le May, Cedric
    Guyomarc'h-Delasalle, Beatrice
    Krempf, Michel
    Costet, Philippe
    ATHEROSCLEROSIS, 2010, 211 (02) : 700 - 702
  • [46] Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease
    Pedreño, J
    Fernández, R
    Ballester, A
    Jornet, A
    Usón, M
    Canela, J
    Petit, M
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 74 (2-3) : 159 - 167
  • [47] Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus
    Feng, Zhicai
    Liao, Xiangyu
    Zhang, Hao
    Peng, Juan
    Huang, Zhijun
    Yi, Bin
    RENAL FAILURE, 2023, 45 (01)
  • [48] Association between plasma PCSK9 levels and lipid profile in patients with Parkinson's disease and comparison with healthy subjects
    Jahed, Mohammad Reza
    Habibi, Seyed Amir Hassan
    Vaseghi, Golnaz
    Amiri, Hasan
    Montazeri, Hamed
    Eshraghi, Azedeh
    CURRENT JOURNAL OF NEUROLOGY, 2022, 21 (04): : 236 - 243
  • [49] The Relationship between Circulating PCSK9 Concentration and Coronary Damage Severity in Patients with Cardiovascular Disease
    Choi, Yeon Kyung
    Bae, Kwi Hyun
    Kim, Mi Jin
    Seo, Jung Beom
    Ham, Hye Jin
    Park, Keun Gyu
    DIABETES, 2017, 66 : A121 - A121
  • [50] Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: The CAVASIC study
    Kheirkhah, Azin
    Lamina, Claudia
    Rantner, Barbara
    Kollerits, Barbara
    Stadler, Marietta
    Pohlhammer, Johannes
    Klein-Weigel, Peter
    Fraedrich, Gustav
    Kronenberg, Florian
    ATHEROSCLEROSIS, 2021, 316 : 41 - 47